Tepotinib suppresses proliferation, invasion, migration, and promotes apoptosis of melanoma cells via inhibiting MET and PI3K/AKT signaling pathways

Malignant melanoma seriously threatens public health and lowers the quality of life of the affected subjects. The present study was designed to explore the effects of tepotinib, a selective tyrosine kinase inhibitor of MET proto-oncogene, receptor tyrosine kinase (MET), on the progression of melanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Guifang, Yu, Fang, Xue, Huandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019857/
https://www.ncbi.nlm.nih.gov/pubmed/35497936
http://dx.doi.org/10.3892/ol.2022.13290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019857/
https://www.ncbi.nlm.nih.gov/pubmed/35497936
http://dx.doi.org/10.3892/ol.2022.13290

Ejemplares similares